Related Experiment Video

Updated: Aug 11, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Treating high blood cholesterol in the older patient

D J Gordon1, B M Rifkind

  • 1Lipid Metabolism-Atherosclerosis Branch, National Institutes of Health, Bethesda, Maryland 20892.

The American Journal of Cardiology
|May 2, 1989
PubMed

Insights

Treating high blood cholesterol in older adults may significantly reduce their absolute risk of coronary heart disease (CHD). Further research is needed to confirm these benefits for the elderly population.

Area of Science:

  • Cardiovascular Medicine
  • Geriatrics
  • Public Health

Background:

  • High blood cholesterol is a known risk factor for coronary heart disease (CHD).
  • The benefits of cholesterol treatment are well-established in younger populations.
  • The application of hypercholesterolemia treatment in elderly patients remains less defined.

Purpose of the Study:

  • To evaluate the potential benefits of treating high blood cholesterol in older adults.
  • To determine if cholesterol management in the elderly can lead to a greater reduction in absolute CHD risk.

Main Methods:

  • This study reviews existing research on hypercholesterolemia and its association with CHD in aging populations.
  • Analysis focuses on the interplay between age, cholesterol levels, and cardiovascular event risk.
  • The study synthesizes data to assess the impact of cholesterol-lowering interventions in the elderly.

Main Results:

  • The association between high cholesterol and CHD risk diminishes with advanced age.
  • However, age is a significant independent risk factor for CHD.
  • Cholesterol treatment in the elderly may offer a substantial reduction in absolute CHD risk compared to younger individuals.

Conclusions:

  • While the relative risk reduction from cholesterol treatment may decrease with age, the absolute risk reduction can be substantial in older adults.
  • Further dedicated research is essential to precisely define the efficacy and benefits of hypercholesterolemia treatment in the elderly population.
  • Optimizing cardiovascular health in aging individuals requires careful consideration of cholesterol management strategies.

More Related Videos

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...